Reverter JC - Search Results

1

[Neoplasms associated with chronic lymphatic leukemia. Incidence and characteristics in a series of 232 patients].

López-Guillermo A, Reverter JC, Cervantes F, Viñolas N, Rovira M, Urbano-Ispizua A, Montserrat E, Rozman C. López-Guillermo A, et al. Among authors: reverter jc. Med Clin (Barc). 1989 Dec 2;93(18):681-3. Med Clin (Barc). 1989. PMID: 2607817 Spanish.

2

Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia.

Villamor N, Reverter JC, Montserrat E, Urbano-Ispízua A, Vives-Corrons JL, Rozman C. Villamor N, et al. Among authors: reverter jc. Leukemia. 1992 Jun;6(6):547-52. Leukemia. 1992. PMID: 1376376

3

[Chronic myelomonocytic leukemia and solid neoplasms: is it a causal or a fortuitous association?].

Rovira M, Cervantes F, Lozano M, Ribera JM, Reverter JC, Rozman C. Rovira M, et al. Among authors: reverter jc. Sangre (Barc). 1989 Jun;34(3):207-9. Sangre (Barc). 1989. PMID: 2762983 Spanish.

4

Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.

Montserrat E, Viñolas N, Reverter JC, Rozman C. Montserrat E, et al. Among authors: reverter jc. Nouv Rev Fr Hematol (1978). 1988;30(5-6):359-61. Nouv Rev Fr Hematol (1978). 1988. PMID: 3222145

5

Impact of response to treatment on survival in multiple myeloma: results in a series of 243 patients.

Bladé J, López-Guillermo A, Bosch F, Cervantes F, Reverter JC, Montserrat E, Rozman C. Bladé J, et al. Among authors: reverter jc. Br J Haematol. 1994 Sep;88(1):117-21. doi: 10.1111/j.1365-2141.1994.tb04986.x. Br J Haematol. 1994. PMID: 7803233

6

Myelomonocytic antigens in B-cell chronic lymphocytic leukemia.

Tàssies D, Montserrat E, Reverter JC, Villamor N, Rovira M, Rozman C. Tàssies D, et al. Among authors: reverter jc. Leuk Res. 1995 Nov;19(11):841-8. doi: 10.1016/0145-2126(95)00064-x. Leuk Res. 1995. PMID: 8551801

7

Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.

Viñolas N, Reverter JC, Urbano-Ispizua A, Montserrat E, Rozman C. Viñolas N, et al. Among authors: reverter jc. Blood Cells. 1987;12(2):457-70. Blood Cells. 1987. PMID: 3620708

8

Timing of diagnosis and lymphocyte accumulation patterns in chronic lymphocytic leukemia: analysis of their clinical significance.

Molica S, Reverter JC, Alberti A, Montserrat E. Molica S, et al. Among authors: reverter jc. Eur J Haematol. 1990 May;44(5):277-81. doi: 10.1111/j.1600-0609.1990.tb00395.x. Eur J Haematol. 1990. PMID: 2369939

9

A new prognostic system for multiple myeloma based on easily available parameters.

Bladé J, Rozman C, Cervantes F, Reverter JC, Montserrat E. Bladé J, et al. Among authors: reverter jc. Br J Haematol. 1989 Aug;72(4):507-11. doi: 10.1111/j.1365-2141.1989.tb04314.x. Br J Haematol. 1989. PMID: 2775656

10

Acute transformation of chronic myelomonocytic leukaemia: a multivariate study of predictive factors.

Ribera JM, Cervantes F, Reverter JC, Montserrat E, Rozman C. Ribera JM, et al. Among authors: reverter jc. Eur J Haematol. 1989 Mar;42(3):284-8. doi: 10.1111/j.1600-0609.1989.tb00113.x. Eur J Haematol. 1989. PMID: 2924891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters